Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physician Sunshine Rule Needs Longer Lead Time Before Implementation, PhRMA Says; Scope Challenged By CROs

Executive Summary

The Pharmaceutical Research and Manufacturers of America seeks at least a six-month lead time before implementation in comments to CMS. The Association for Clinical Research Organizations takes issue with including payments for “legitimate” research in the rulemaking at all.

You may also be interested in...



“Sunshine” Might Bring Public Awareness Campaign On Medical Research

Final CMS reg on reporting industry payments to physicians include limiting coverage to companies operating in the U.S. and a definition of third-party payments; despite wins in the revisions from the proposed rule, industry may need a widespread education campaign in order to preserve the value of its physician relationships.

Six Months Till Sunrise: CMS Allows Extra Time For Firms To Collect Physicians Payment Data

Drug makers get three more months to comply than the proposed rule offered; firms must send the data by March 31, 2014, to CMS, which plans to make the information available on a public website by Sept. 30, 2014.

Still Cloudy: CMS “Hopeful” Some Sunshine Data Collection Begins In 2013

CMS is still unable to provide certainty regarding the timeline for releasing a final rule implementing the Sunshine Act, Policy and Data Analysis Group Director Niall Brennan told a congressional roundtable on the issue Sept. 12.

Related Content

Topics

UsernamePublicRestriction

Register

OM016276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel